Early results of intratumoral INT230-6 alone or in combination with ipilimumab in subjects with advanced sarcomas.

Matthew Ingham,James S. Hu,Giles F. Whalen,Jacob Stephen Thomas,Anthony B. El-Khoueiry,Diana L. Hanna,Anthony J. Olszanski,Christian F. Meyer,Nilofer S. Azad,Syed Mahmood,Lewis H. Bender,Ian B. Walters,Albiruni Ryan Abdul Razak,Lillian L. Siu

Early results of intratumoral INT230-6 alone or in combination with ipilimumab in subjects with advanced sarcomas.

2021

Matthew Ingham
James S. Hu
Giles F. Whalen
Jacob Stephen Thomas
Anthony B. El-Khoueiry
Diana L. Hanna
Anthony J. Olszanski
Christian F. Meyer
Nilofer S. Azad
Syed Mahmood
Lewis H. Bender
Ian B. Walters
Albiruni Ryan Abdul Razak
Lillian L. Siu

11557Background: Patients have limited treatment options following initial chemotherapy failure. INT230-6, a novel formulation of cisplatin (CIS) and vinblastine (VIN) with an amphiphilic cell pene...

Keywords:

treatment options
Ipilimumab
Chemotherapy
early results
Cell
Internal medicine
Oncology
Medicine
Vinblastine
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations